RecruitingNCT07388992

Investigating Specific Gait Patterns in Individuals Living With Multiple Sclerosis

Sponsor

SYSNAV

Enrollment

30 participants

Start Date

Mar 16, 2026

Study Type

OBSERVATIONAL

Conditions

The study aims to investigate specific ambulation patterns characteristic of the quality of gait in people with MS (pwMS)

Min Age: 18 YearsMax Age: 65 Years

For people living with multiple sclerosis (pwMS):
Age at inclusion between =18 and =65 years old
Signed informed consent and ability to comply with study and follow-up.
Confirmed MS diagnosis according to McDonald criteria (2017)
Expanded Disability Status Scale EDSS = 6
Stable treatment for 2 months before inclusion (for both disease modifying and symptomatic therapies)
Ability and willingness to participate in and comply with all study procedures defined in the protocol
Subject will be eligible for enrollment in this study only if either affiliated to, or a beneficiary of a social security category
For Healthy volunteers :
Age at inclusion between =18 and =65 years old
Signed informed consent and ability to comply with study and follow-up.
Ability and willingness to participate in and comply with all study procedures defined in the protocol
Subject will be eligible for enrollment in this study only if either affiliated to, or a beneficiary of a social security category

For pwMS:
Participants with a relapse within the past 3 months before the inclusion
Participants with significant cognitive disorders, limiting the understanding of the exercises to be performed or presence of apparent communication difficulties hindering the correct collection of data, as assessed by the investigator
Past or present pathology other than MS or surgery or trauma impacting gait, ambulatory function or upper limb function, as assessed by the investigator
Vulnerable adults: individuals subject to a legal protection measure (guardianship, limited guardianship, or judicial protection) or unable to express their consent.
For healthy volunteers (HV):
Participants with significant cognitive disorders, limiting the understanding of the exercises to be performed or presence of apparent communication difficulties hindering the correct collection of data, as assessed by the investigator
Past or present pathology or surgery or trauma impacting gait, ambulatory function or upper limb function, as assessed by the investigator
Vulnerable adults: individuals subject to a legal protection measure (guardianship, limited guardianship, or judicial protection) or unable to express their consent.

Interested in this trial?

Get notified about updates and connect with the research team.

CHU Lille

Lille, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

NCT07388992